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INTRODUCTION
Minoxidil, a pyrimidine derivative (2,4-diamino-6-pipe-
ridino-pyrimidine-3-oxide), is an adenosine triphosphate
(ATP)-sensitive potassium channel (KATP channel) opener,
and is reported to exert growth-promoting effects on follic-
ular epithelial cells and to stimulate the rapid anagen induc-
tion of hair cycles (1, 2). Although the mechanism of minox-
idil promoting hair growth is still speculative, minoxidil was
reported to mediate its effect through the growth factors-
related ways, to increase blood circulation around hair folli-
cles and in addition, markedly to elevate 17 -hydroxysteroid
dehydrogenase activity that accelerates the conversion of tes-
tosterone to weaker androgen (extensively reviewed in [3]).
Recently, it was also reported that the expression of genes
encoding potassium channels and related genes was upregu-
lated in hair follicle bulge stem cells (4). 
Vitamin A and its active derivatives such as retinoic acid
have been reported to play an important role in the growth,
differentiation and maintenance of hair follicles (5, 6). Topi-
cal application of all-trans retinoic acid (ATRA) is known to
control hair growth cycle (7). ATRA has been suggested to
stimulate the growth of sub-optimal hairs and act synergis-
tically with minoxidil, producing more dense hairs than either
compound alone (8). ATRA was also reported to enhance
the percutaneous absorption of minoxidil by increasing the
stratum corneum permeability (9).
Recently, we have shown that minoxidil prolongs anagen
stage resulting in promoting hair growth by engaging two
mechanisms: the activation of Erk and Akt that enhances
the survival of cultured human dermal papilla cells (DPCs)
and the increase of the ratio of Bcl-2/Bax that protects cells
against cell death (10). The aim of this study was to evalu-
ate the possible interaction of minoxidil and ATRA on hair
growth in vitro, and to investigate the effect of minoxidil in
combination with ATRA on normal human epidermal kera-
tinocytes (NHK) as an epithelial counterpart in addition to
the suggested system in cultured dermal papilla cells (DPCs).
MATERIALS AND METHODS
Drugs and reagents
Minoxidil and ATRA were purchased from Sigma (St Louis,
MO, U.S.A.). Minoxidil was dissolved in 0.12 mM HCl and
1.0 mM minoxidil stock solution was stored at -20℃. ATRA
was dissolved in dimethylsulfoxide (DMSO). 0.1 mM ATRA
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Promotive Effect of Minoxidil Combined with All-trans Retinoic Acid
(tretinoin) on Human Hair Growth in Vitro
Minoxidil induces hair growth in male pattern baldness and prolongs the anagen
phase. All-trans retinoic acid (ATRA) has been reported to act synergistically with
minoxidil in vivo: they can enhance more dense hair regrowth than either compound
alone. We evaluated the effect of minoxidil combined with ATRA on hair growth in
vitro. The effect of co-treatment of minoxidil and ATRA on hair growth was studied
in hair follicle organ culture. In cultured human dermal papilla cells (DPCs) and nor-
mal human epidermal keratinocytes, the expressions of Erk, Akt, Bcl-2, Bax, P53
and P21 were evaluated by immunoblot analysis. Minoxidil plus ATRA additively pro-
moted hair growth in vitro, compared with minoxidil alone. In addition, minoxidil plus
ATRA elevated phosphorylated Erk, phosphorylated Akt and the ratio of Bcl-2/Bax,
but decreased the expressions of P53 and P21 more effectively than by minoxidil
alone. Our results suggest that minoxidil plus ATRA would additively enhance hair
growth by mediating dual functions: 1) the prolongation of cell survival by activating
the Erk and Akt signaling pathways, and 2) the prevention of apoptosis of DPCs
and epithelial cells by increasing the ratio of Bcl-2/Bax and downregulating the ex-
pressions of P53 and P21.
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stock solution was shielded from the light with aluminum
foil until required. 
Anti-phosphorylated Erk-1/2 (Thr202/Tyr 204) antibody,
anti-total Erk-1/2 antibody, anti-phosphorylated Akt (Ser473)
antibody, and anti-total Akt antibody were purchased from
Cell Signaling Technology, Inc. (Beverly, MA, U.S.A.). Anti-
Bcl-2 and anti-Bax antibodies were obtained from Dako (Glo-
strup, Denmark). Anti-P53 (DO7) antibody was obtained
from Novocastra (Newcastle, U.K.). Anti-P21 antibody was
obtained from Oncogene (San Diego, CA, U.S.A.). Anti- -
actin antibody was obtained from Santa Cruz Biotech Inc.
(Santa Cruz, CA, U.S.A.). 
Human hair follicle samples
Tissue samples of the occipital scalp region were obtained
by excisional biopsy. Ten healthy male volunteers, aged bet-
ween 20 and 35 yr, were recruited. The subjects did not have
a current or prior disease and were not under medication for
at least 1 month. The Institutional Review Board at the Seoul
National University Hospital approved all procedures used
in this study. Written informed consents were obtained from
all volunteers. Tissue samples containing more than 100 hair
follicles were cautiously dissected into single hair follicles.
We used hair follicles morphologically in the anagen stage
only determined as described previously (11). 
Hair follicle organ culture 
Human scalp hair follicles were isolated and cultured in
vitro as described previously (12). Briefly, dissected hair folli-
cle was cut into small pieces approximately 2.5 mm in length
from the bottom of dermal papilla and cultured in Williams
E medium (Gibco BRL, Gaithersburg, MD) with 10 ng/mL
hydrocortisone, 10  g/mL insulin, 2 mM L-glutamine, and
100 U/mL penicillin at 37℃in 5% CO2atmosphere. Minox-
idil alone or in combination with ATRA was added to the
culture medium. Minoxidil was used at 1  M. ATRA was
used at the final concentration ranged from 1 nM to 10 nM. 
A total of 180 anagen hair follicles from 3 different vol-
unteers (60 follicles per subject) were cultured in triplicates
under 4 different growth conditions. The data are presented
as the means±SEM. In all experiments, tissue culture me-
dium containing minoxidil alone or minoxidil plus ATRA
was changed every other day. After culturing for 12 days,
the hair growth was measured directly using an Olympus
stereomicroscope with an eyepiece containing a graticule.
Culture of dermal papilla cells and normal human epider-
mal keratinocytes 
Human DPCs were cultured as described previously (13).
Briefly, DPCs were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Gibco BRL, Gaithersburg, MD, U.S.A.)
containing 2 mM L-glutamine, 1× antibiotic antimycotic
solution (1,000 units/mL of penicillin G sodium and 2.5  g/
mL of amphotericin B) and 10% fetal bovine serum (Hyclone,
Logan, UT, U.S.A.) at 37℃, in a 5% CO2 incubator. The
fourth-passage DPCs were used. 
As follicular and nonfollicular epidermal keratinocytes are
known to respond similarly to minoxidil treatment (14), we
used NHK of five human adult foreskins obtained from cir-
cumcisions. NHK were isolated as previously described (15)
and cultured in keratinocyte growth medium (Clonetics, San
Diego, CA, U.S.A.) composed of MCDB 153 medium sup-
plemented with epidermal growth factor (10 ng/mL), bovine
pituitary extract (70  g/mL), hydrocortisone (0.5  g/mL),
insulin (5  g/mL), penicillin (100  g/mL) and fungizone
(0.25  g/mL). The NHK were cultured until 80% conflu-
ent in tissue culture flasks (Becton Dickinson, Lincoln Park,
NJ, U.S.A.) at 37℃ and 5% CO2 and stored in liquid nitro-
gen until use. At the time of the experiments, the cells were
thawed and third passage cells were used.
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium
Bromide (MTT) assay
As a parameter to check for cytotoxic effect of minoxidil
plus ATRA, cell viability was measured using the MTT assay
as previously described (16). DPCs and NHK of 1.5×104
cells/well were seeded into 96-well plates, cultured for 24 hr
in serum-free DMEM, and treated with the vehicle (0.12 mM
HCl/DMSO diluted 1:1,000 in DMEM) as control, and the
various combined concentrations of ATRA (0.01-1 nM) and
minoxidil (0.01-1.0  M) for 5 days. 20  L MTT solution (5
mg/mL) was added to a well, incubated for 4 hr at 37℃ in
the dark, removed the supernatants, added 200  L DMSO to
dissolve formazan products, incubated for 30 min at room
temperature, and the absorbance was measured at 570 nm
using an ELISA reader. The results were expressed as the per-
centage of control cells in six same culture conditions.
Western blot analysis after treatment with minoxidil alone
or minoxidil plus ATRA on the dermal papilla cells and
keratinocytes
For the treatment with minoxidil alone or minoxidil plus
ATRA, confluent DPCs and NHK were incubated for 24 hr
in serum-free DMEM and treated with the vehicle (0.12 mM
HCl and/or DMSO diluted at 1:1,000 in DMEM in half),
minoxidil alone (0.1  M), or 0.1  M minoxidil plus 0.1 nM
ATRA for 1 hr for the evaluation of Erk and Akt, and for
24 hr for the evaluation of Bcl-2/Bax and P53/P21.
Western blot analysis was performed as follows. Briefly,
proteins were extracted using the buffer containing 50 mM
Tris-HCl (pH 7.4), 2 mM EDTA, 100  g/mL leupeptin,
20  g/mL aprotinin, and 100 mM NaCl. The supernatant
was collected and kept at -70℃ until used. Fifty microgramof protein was loaded to a lane of 10% or 12% SDS-poly-
acrylamide gel, separated by electrophoresis, and blotted onto
nitrocellulose membrane. The blotted membrane was incu-
bated with primary antibody (anti-total Erk polyclonal anti-
body, 1:500; anti-phosphorylated Erk polyclonal antibody,
1:500; anti-total Akt polyclonal antibody, 1:500; anti-phos-
phorylated Akt polyclonal antibody, 1:500; anti-Bcl-2 mon-
oclonal antibody, 1:1,000; anti-Bax monoclonal antibody,
1:1,000; anti-P53 monoclonal antibody, 1:1,000; anti-P21
monoclonal antibody, 1:1,000; anti- -actin monoclonal anti-
body, 1:1,000) at 4℃ overnight. The membrane was incu-
bated with the anti-mouse IgG-HRP conjugate (1:2,000) or
the anti-rabbit IgG-HRP conjugate (1:2,000) for 1 hr at room
temperature. The antibody-antigen complex was detected
using the ECL system (Amersham Pharmacia Biotech; Lit-
tle Chalfont, U.K.) and analyzed using a Bio-Rad GS-700
imaging densitometer (Hercules, CA, U.S.A.). 
Statistical analysis
Statistical significance was determined using the ANOVA
multiple comparison test and Wilcoxon-rank sum test. pvalue
of less than 0.05 was considered statistically significant.
RESULTS
Minoxidil plus ATRA enhanced hair growth more efficiently
than minoxidil alone in vitro
Compared with minoxidil alone, the growth-promoting
activity of the minoxidil plus ATRA was examined in in
vitro human hair follicle culture model. Minoxidil at 1  M
enhanced hair growth significantly compared with vehicle-
treated control (p<0.05) (Fig. 1). The minoxidil plus ATRA
(1 nM) more increased hair growth by 4.2±0.7 mm com-
pared with mioxidil alone (p<0.05). Combination of the
higher concentration of ATRA (10 nM) was less effective
than the mixture of minoxidil plus 1 nM ATRA, although
the enhanced hair growth by mixed preparation with 10 nM
ATRA was at least not less than the minoxidil alone. 
Minoxidil plus ATRA induced the proliferations of DPCs
and NHK
Minoxidil (0.01-1  M) plus ATRA (0.01-1 nM) enhanced
the proliferations of cultured DPCs and NHK. The enhance-
ment was the greatest at minoxidil 0.1  M plus ATRA 0.1
nM by 189.7±42.1% (mean±SD) in DPCs and by 219.5
±57.8% in NHK.
Minoxidil plus ATRA increased the phosphorylation of Erk
in DPCs and NHK more effectively than minoxidil alone
Treated with minoxidil, the phosphorylated Erk (p-Erk)
level in DPCs was significantly increased to 214±21%. The
minoxidil plus ATRA more significantly elevated the p-Erk
level to 298±50% (p<0.05) (Fig. 2A). The NHK from five
different donors was tested with minoxidil alone or minoxi-
dil plus ATRA and in the experiment, it has to be mentioned
that NHK from 2 donors did not respond to the treatment.
The expression of p-Erk in other three samples was slightly
elevated to 106±4% by treatment of minoxidil. Minoxidil
plus ATRA increased the expression of p-Erk to 207±51%
(Fig. 2B). 
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Fig. 1. The effect of minoxidil plus ATRA on hair growth in vitro.
Hair follicle organ culture was performed in triplicates with hair
follicles obtained from the occipital scalp of three volunteers. Hair
growth is enhanced by minoxidil at 1  M. Minoxidil plus ATRA
promotes hair growth more significantly, especially at a concen-
tration of 1  M minoxidil and 1 nM ATRA. Moreover, the increase
in hair growth was significant compared with minoxidil alone. Val-
ues were obtained after cumulative growth of 15 hair follicles per
each growth condition for 12 days and shown as the means±SEM.
*, p<0.05; 
� , p<0.01.
Fig. 2. The effect of minoxidil and ATRA on the p-Erk and on total
Erk in (A) DPCs and in (B) NHK. The level of p-Erk increased sig-
nificantly after treatment of minoxidil, and minoxidil plus ATRA more
enhanced the expression of p-Erk. The representative bands of
triplicate experiments are shown. The values shown are the means
±SEM of % elevation compared with the vehicle-treated control
from three different DPCs and NHK cultures. *, p<0.05, compared
with the vehicle-treated control. p-Erk, phosphorylated Erk; T-Erk,
total Erk; M, minoxidil. 
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The total Erk level was barely changed in response to mi-
noxidil alone or minoxidil plus ATRA in both cells. The val-
ues shown are the means±SEM of percentage increases ver-
sus the control from three different batches of DPCs or NHK. 
Minoxidil plus ATRA increased the phosphorylation of Akt
in DPCs and NHK more efficiently than minoxidil alone
Minoxidil enhanced the level of phosphorylated Akt (p-
Akt) to 126±8% in DPCs and the minoxidil plus ATRA
more increased the phosphorylation of Akt to 315±8% (p<
0.05) (Fig. 3A). 
The expression of p-Akt in the NHK from the three donors
increased in a similar manner with DPCs by minoxidil alone
and minoxidil plus ATRA to 111±10% and 284±56%,
respectively (Fig. 3B). The expression of p-Akt was not ele-
vated in the same two cells that were irresponsive to the treat-
ment in p-Erk. Minoxidil alone and minoxidil plus ATRA
had no effect on the expression of total Akt in both cells. 
Minoxidil plus ATRA increased the Bcl-2 expression and
decreased the Bax expression in DPCs and NHK more
efficiently than minoxidil alone
To evaluate the possible association in changes on Bcl-2
family proteins, we investigated the effects of minoxidil alone
or minoxidil plus ATRA on the expressions of Bcl-2 and Bax
protein. Treated with minoxidil, the expression of Bcl-2 pro-
tein was increased in DPCs to 128±18%. The increase, how-
ever, was not statistically significant. Minoxidil plus ATRA
Fig. 3. The increase of p-Akt expression by minoxidil and ATRA.
(A) In DPCs, minoxidil increases p-Akt, moreover, minoxidil plus
ATRA more significantly elevates the p-Akt level. (B) In NHK, mi-
noxidil alone and minoxidil plus ATRA increase p-Akt expression,
however, they were statistically insignificant. The blotted bands
are the representative of triplicate experiments. The values are
shown as the means±SEM of % elevation compared with con-
trols. *, p<0.05, compared with controls treated with the vehicle.
p-Akt, phosphorylated Akt; T-Akt, total Akt; M, minoxidil.
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Fig. 4. The effect of minoxidil and ATRA on the expression of Bcl-2
and Bax protein in DPCs and NHK. Compared with vehicle-treat-
ed control, minoxidil plus ATRA significantly increases the expres-
sion of Bcl-2 in DPCs (A) and in NHK (B). (C) Minoxidil significantly
decreases the expression of Bax. Minoxidil plus ATRA suppresses
the expression of Bax more efficiently in DPCs. (D) Expression of
Bax in NHK is also significantly decreased by minoxidil plus ATRA.
The bands are the representatives of triplicate experiments. The
values are shown as the means±SEM of % elevation in compari-
son with the controls. *, p<0.05 compared with vehicle-treated
control. M, minoxidil.
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Fig. 5. The effects of minoxidil and ATRA on the expressions of
P53 and P21 protein in DPCs and NHK. (A) Minoxidil alone and
minoxidil plus ATRA significantly suppress the expression of P53
protein in DPCs. (B) In NHK, minoxidil plus ATRA decreases P53
expression significantly. (C) In DPCs, Minoxidil significantly dec-
reases the expression of P21. Minoxidil plus ATRA reduces the
expression of P21 more significantly. (D) P21 expression is sig-
nificantly downregulated with minoxidil plus ATRA. The bands
are the representative of triplicate experiments. *, p<0.05 com-
pared with the vehicle-treated control. The data are shown as
the means±SEM of % elevation compared with controls from
three different DPC and NHK cultures. M, minoxidil. 
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Delevated the Bcl-2 expression to 200±73% with statistical
significance (p<0.05) (Fig. 4A). For NHK, the expression of
Bcl-2 protein was increased similarly; elevated Bcl-2 expres-
sion to 206±38% with minoxidil alone, and with minoxi-
dil plus ATRA, to 325±68% (Fig. 4B).
In contrast, minoxidil decreased the Bax protein expression
significantly in DPCs, to 75±3%. Minoxidil plus ATRA
more significantly downregulated the expression of Bax to
45±10% (p<0.05) (Fig. 4C). Minoxidil alone or minoxidil
plus ATRA also decreased the Bax protein expression signifi-
cantly in NHK to 83±7% and to 47±9%, respectively
(p<0.05) (Fig. 4D).
Minoxidil plus ATRA downregulated the expressions of
P53 and P21 in DPCs and NHK more efficiently than
minoxidil alone
P53 plays a pivotal role in the regulation of cell growth
and programmed cell death. P21 is a specific downstream
target of P53 that mediates the cell cycle arrest (17). Treated
in DPCs, minoxidil alone and minoxidil plus ATRA down-
regulated the expression of P53 to 59±2% and to 47.5±
10%, respectively (p<0.05) (Fig. 5A). For NHK, expression
patterns of P53 were also decreased significantly by minoxi-
dil plus ATRA (p<0.05) (Fig. 5B).
Similarly, minoxidil decreased the expression of P21 to 65
±4% in DPCs. The minoxidil plus ATRA decreased the
level of P21 more efficiently to 45±5% (p<0.05) (Fig. 5C).
In NHK, P21 expression was declined to 93±4% with
minoxidil alone, and to 52±10% by minoxidil plus ATRA
(p<0.05) (Fig. 5D).
DISCUSSION
All-trans retinoic acid, alone or in combination with minox-
idil, has been reported to shorten the second telogen phase
and lengthen the second anagen phase in the C3H mouse
model (7). In this study, we demonstrated that the minoxi-
dil plus ATRA additively enhances hair growth in in vitro
human hair follicles, compared with minoxidil alone.
Previously, minoxidil was reported to have the concentra-
tion-dependent biphasic effect on proliferation and differen-
tiation; growth stimulation at low doses or anti-proliferative,
pro-differentiative and partially cytotoxic effects at high doses
(14). At 10 nM of ATRA co-treated with minoxidil, less
elongation than at 1 nM suggested that ATRA might increase
the tissue concentration of minoxidil in hair follicles in vitro.
Although ATRA is converted to other active metabolites
in the dermis, the doses used in organ culture would be com-
patible to the dermal concentration in vivo, because the con-
centration of commercially available topical ATRA is 0.01-
0.1% and in human cadaver skin, 0.11-0.44% of ATRA is
deposited in the dermis by topical application (18). 
The cellular and molecular basis of ATRA mediating cell
proliferation and the formation of extracellular matrix has
not been delineated. ATRA at 1 nM was reported to extend
the life span of human oral and epidermal keratinocytes by
decreasing the expression of senescence-associated genes (p53,
p21, p16) and maintaining telomerase activity, but at higher
concentrations the replicative senescence was enhanced in a
dose-dependent manner (19). 
We demonstrated here that minoxidil plus ATRA addi-
tively increased the phosphorylation of Erk in both DPCs
and NHK, compared with minoxidil alone. The role of the
Erk signaling pathway in cell growth has been well estab-
lished (20). The diverse involvement of retinoic acid has been
demonstrated in the regulation of developmental processes
and the modulation of differentiation in various cellular mod-
els by the MAPK pathways (21, 22). The MAPK pathway is
also involved in maintaining cell survival by modulating
apoptotic molecules including Bcl-2 family (23). The PI3
kinase/ Akt cascade plays a crucial role in cell survival and
the prevention of apoptosis (24, 25). The crosstalk between
Erk and PI3K/Akt pathway has been demonstrated to pro-
long cell survival (26). Our results thus suggest that the acti-
vation of Akt, an anti-apoptotic molecule, by minoxidil plus
ATRA may prolong survival of DPCs and epithelial coun-
terpart.
The Bcl-2 family proteins are structurally related molecules
that play an essential role in the regulation of apoptosis (27).
Bcl-2 family consists of anti-apoptotic proteins such as Bcl-
2 as well as pro-apoptotic proteins such as Bad and Bax. Erk
and PI3K/Akt pathways synergistically induce cell survival
by Bcl-2 cascade (28). Throughout the hair cycle, dermal
papilla (DP) is the only region expressing consistently Bcl-2
proteins and the Bax proteins are not detected during hair
cycles (29, 30). The DP thus is considered to be resistant
apoptosis. On the other hand, the downregulation of Bcl-2
expression has been shown to induce apoptosis of DPCs in
tissue culture (31). The relative amount of Bcl-2 over Bax is
known to determine the fate of living cells (32). Retinoid
treatment has been reported to increase the ratio of mRNAs
encoding bcl-2 and bax significantly (33). Our data suggest
that minoxidil plus ATRA additively promote cell survival
by the modulation of the ratio of Bcl-2 and Bax in DPCs and
NHK.
P53 is a tumor suppressor gene that plays a pivotal role in
the regulation of cell growth and cell death. The downstream
transcriptional targets of P53 are the cyclin-dependent kinase
inhibitor P21WAF1 that mediates G1 arrest and Bax that is
involved in apoptosis (17). In addition, bcl-2 gene was demon-
strated to act as a transcriptional target for wild-type P53
that downregulates the endogenous Bcl-2 expression and
upregulates the Bax expression (34). Moreover, in addition
to transcriptional activation, P53-dependent apoptosis may
be induced through a transactivation-independent means,
such as by the induction of oxidative stress, the inhibition
Minoxidil and Tretinoin on in Vitro Hair Growth 287of RNA, or the inhibition of protein synthesis (35). In this
study, minoxidil plus ATRA worked together to suppress
the expression of P53 and its downstream target P21, although
the exact mechanism has to be elucidated in future experi-
ments.
In summary, our data suggest that the enhanced hair growth
by minoxidil plus ATRA in our short-term organ culture
may be explained through prolonged survival of epithelial
cells and DPCs, which mediate signals for follicular epithe-
lium. Minoxidil plus ATRA more increased the phosphoryla-
tion of Erk and Akt early 1 hr after the treatment than mino-
xidil alone. The change of Bcl-2/Bax ratio, P53 and P21 were
also detected later 24 hr after the treatments. Minoxidil plus
ATRA could work together to prolong the survival of cul-
tured DPCs and epithelial cells and to protect them from
apoptosis by dual mechanisms with different kinetics: 1) the
activation of Erk- and Akt-dependent pathways and 2) the
increase of the ratio of Bcl-2/Bax and the suppression of the
expression of P53 and its downstream target P21.
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